Litigation Details for SENJU PHARMACEUTICAL CO., LTD. v. LUPIN, LTD. (D.N.J. 2014)
✉ Email this page to a colleague
SENJU PHARMACEUTICAL CO., LTD. v. LUPIN, LTD. (D.N.J. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-01-31 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 15:1126 Patent Infringement | Assigned To | Jerome B. Simandle |
| Jury Demand | None | Referred To | Magistrate Judge Karen M. Will |
| Patents | 8,129,431; 8,669,290; 8,754,131; 8,871,813; 8,927,606 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SENJU PHARMACEUTICAL CO., LTD. v. LUPIN, LTD.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for SENJU PHARMACEUTICAL CO., LTD. v. LUPIN, LTD. (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-01-31 | 1 | United States Patent No. 8,129,431 (“the ’431 patent”), arising under the United States patent laws, Title… COUNT FOR PATENT INFRINGEMENT 11. The U.S. Patent and Trademark Office …Office (“PTO”) issued the ’431 patent on March 6, 2012. The ’431 patent claims, inter alia, formulations of…Senju is the assignee of the ’431 patent. A copy of the ’431 patent is attached hereto as Exhibit A. …. COMPLAINT FOR PATENT INFRINGEMENT Plaintiffs Senju Pharmaceutical | External link to document | |
| 2015-11-18 | 107 | the various patents covering Plaintiffs’ Prolensa® product: U.S. Patent Nos. 8,129,431 (“the ’431…of U.S. Patent No. 8,129,431, IPR2015-00903 (Innopharma); Inter Partes Review of U.S. Patent No. 8,754,131… The patents at issue in this case, namely, the ’431 patent, the ’290 patent, the ’131 patent, the …431 patent”), 8,669,290 (“the ’290 patent”), 8,754,131 (“the ’131 patent”), 8,871,813 (“the ’813 patent…patent”), and 8,927,606 (“the ’606 patent”) (collectively, the “patents- in-suit”). Before the | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
